Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid ArthritisClaire Bombardier, Thomas J. Schnitzer|New England Journal of Medicine|2000Cited by 4k
Clopidogrel with or without Omeprazole in Coronary Artery DiseaseDeepak L. Bhatt, Christopher P. Cannon, Byron Cryer et al.|New England Journal of Medicine|2010Cited by 1.2k
Towards a mechanism-based approach to pain management in osteoarthritisAnne‐Marie Malfait, Thomas J. Schnitzer|Nature Reviews Rheumatology|2013Cited by 304
A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy Fleischmann, Marc C. Levesque, Jean‐Pierre Pelletier et al.|Arthritis & Rheumatology|2019Cited by 209
THE NITRIC OXIDE DONATOR NAPROXCINOD HAS BLOOD PRESSURE EFFECTS SIMILAR TO PLACEBO IN PATIENTS ON RENIN-ANGIOTENSIN SYSTEM BLOCKERS: 9D.02W WHITE, M. Weber, Thomas J. Schnitzer et al.|Journal of Hypertension|2010Cited by 3